- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01530165
(Pakistan Diabetes Prevention Program PDPP) (PDPP)
January 3, 2014 updated by: Dr. Asma Ahmed, Aga Khan University
A Translation Randodomized Trial of Culturally Specific and Cost Effective Life Style Intervention for the Prevention of Type 2 Diabetes in Pakistan
The Karachi-based Pakistan Diabetes Prevention Study aims to address key issues in the prevention of type 2 diabetes.
Approximately 20,000 people From four communities will be screened for diabetes risk factors using a non-invasive diabetes risk-score system.
Those found to be at increased risk will be given an oral glucose tolerance test.
People who, after the oral glucose tolerance test, are identified as having prediabetes will have the opportunity to take part in the Pakistan Diabetes Prevention Study lifestyle intervention.
This consists of culturally adjusted preventive strategies focusing on diet and physical activity in real-life settings.
Another important aspect of this trial will be to assess the impact of urban planning on the prevalence of obesity and diabetes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74800
- The Aga Khan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 64 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
-Adult men and women between 30-64 years of age
Exclusion Criteria:
- Diagnosed type 1 or type 2 diabetes
- Pregnancy or presence of chronic disease rendering survival for three years unlikely
- Any psychological or physical disability to interfere with participation in the study
- Ischemic heart disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Standard
Pre diabetics randomized to control arm will receive standard life style advice which is given to all pre diabetics seeking medical advice.
|
The main goals of intervention will focus mainly on: Weight reduction ≥ 5% , moderate intensity physical activity ≥ 30 min daily, dietary fat <30 proportion of total energy, saturated fat <10%, Fiber ≥ 15g/1,000 kcal There will be 9 sessions during the two years course of follow-up
|
EXPERIMENTAL: life style intervention arm
This arm would be given aggressive life style intervention in comparison to standard (control) arm.
The intervention would consist of nutritional and physical activity advice.
|
The main goals of intervention will focus mainly on: Weight reduction ≥ 5% , moderate intensity physical activity ≥ 30 min daily, dietary fat <30 proportion of total energy, saturated fat <10%, Fiber ≥ 15g/1,000 kcal There will be 9 sessions during the two years course of follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Type 2 Diabetes
Time Frame: 2 yrs
|
Incidence of type 2 diabetes based on OGTT, diagnosed by WHO criteria at interim and end of an intervention.
|
2 yrs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost effectiveness
Time Frame: 2 years
|
Cost effectiveness by assessing the incremental costs and benefits per case of diabetes prevented and per quality adjusted life year (QALY).
|
2 years
|
Components of Metabolic syndrome
Time Frame: 2 years
|
To assess the difference in incidence of components of metabolic syndrom which includes waist circumference, dyslipidimia, blood pressure etc between control and intervention arm after 2 years of lifestyle intervention.
|
2 years
|
The impact of city planning on prevalence of obesity and type 2 diabetes
Time Frame: 2 years
|
The communities will be divided according to number and accessibility of parks.
The community with large number of parks will be compared with community with no parks and then change in incidence of diabetes and obesity after 2 years of lifestyle intervention will be assessed and compared between two communities.
By this it would be feasible to convince local authorities to incorporate this into their agenda for future urban design.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Asma Ahmed, MRCP(UK), The Aga Khan University Hospital
- Principal Investigator: Jaweed Akhter, FRCP, The Aga Khan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (ANTICIPATED)
October 1, 2014
Study Completion (ANTICIPATED)
October 1, 2015
Study Registration Dates
First Submitted
November 21, 2011
First Submitted That Met QC Criteria
February 7, 2012
First Posted (ESTIMATE)
February 9, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
January 6, 2014
Last Update Submitted That Met QC Criteria
January 3, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DS10-A5
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prediabetic State & High Risk Individuals
-
Yonsei UniversityNot yet recruitingHealthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular DiseaseKorea, Republic of
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
Heidelberg UniversityUnknownFocus: Immunocompromised Individuals at High Risk of Aqcuiring Invasive AspergillosisGermany
-
Cukurova UniversityCompletedPregnancy, High Risk | Anxiety State | Sleep QualityTurkey
-
United Arab Emirates UniversityMohammed Bin Rashid University of Medicine and Health SciencesCompletedCardiovascular Risk Factor | Pre Diabetes | High Blood Pressure | Elevated LDL CholesterolUnited Arab Emirates
-
University of PittsburghRecruitingNormal and Overweight Individuals at High-risk of DiabetesUnited States
-
London School of Hygiene and Tropical MedicineUniversity of California, DavisCompleted
-
Fayoum UniversityCompletedAssess Level of High Sensitive CRP in Diabetics and Prediabetics
-
Rigshospitalet, DenmarkUniversity of Cambridge; Lundbeck FoundationRecruitingHealthy Individuals | Obsessive-Compulsive Disorder/High Compulsive IndividualsDenmark
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
Clinical Trials on Life style counseling
-
Sykehuset Innlandet HFThe Royal Norwegian Ministry of HealthCompleted
-
Clalit Health ServicesCompleted
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
University of TurkuUnknownAtherosclerosisFinland
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
Radboud University Medical CenterCompletedCardiovascular DiseasesNetherlands
-
Glostrup University Hospital, CopenhagenLundbeck Foundation; Sygekassernes HelsefondCompletedPhysical Activity | Sedentary Behavior | Life StyleDenmark
-
Helsinki University Central HospitalUniversity of Helsinki; University of Eastern FinlandNot yet recruitingFertility Disorders | Life Style
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownDiabetes MellitusTaiwan